Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soon Thye Lim

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
Cancer Reports (Hoboken, N.J.)|April 28, 2022
Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapyTricia Tay, Nagavalli Somasundaram, Cindy Lim, et al.
Nature Genetics|June 11, 2013
Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese populationDennis E K Tan, Jia Nee Foo, Jin-Xin Bei, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 10, 2023
Single-Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T-Cell LymphomaYi-Qi Li, Chun-Ling Luo, Jia-Xin Jiang, et al.
Leukemia|December 20, 2024
Genetic susceptibility of diffuse large B-cell lymphoma: a meta genome-wide association study in Asian populationQian Cui, Wen Tan, Bao Song, et al.
Cancer Discovery|June 19, 2012
Janus kinase 3-activating mutations identified in natural killer/T-cell lymphomaGhee Chong Koo, Soo Yong Tan, Tiffany Tang, et al.
Blood Cancer Journal|November 14, 2018
Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK/T cell lymphomaJason Yongsheng Chan, Alvin Yu Jin Ng, Chee Leong Cheng, et al.
Cancers|January 22, 2021
T-Cell Lymphoma Clonality by Copy Number Variation Analysis of T-Cell Receptor GenesMing Liang Oon, Jing Quan Lim, Bernett Lee, et al.
Blood|September 29, 2019
Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistryCatalina Amador, Timothy C Greiner, Tayla B Heavican, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2024
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP TrialVincent Camus, Catherine Thieblemont, Philippe Gaulard, et al.
The Lancet. Oncology|February 14, 2016
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysisSeok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Cancer Reports (Hoboken, N.J.)|April 28, 2022
Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapyTricia Tay, Nagavalli Somasundaram, Cindy Lim, et al.
Nature Genetics|June 11, 2013
Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese populationDennis E K Tan, Jia Nee Foo, Jin-Xin Bei, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 10, 2023
Single-Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T-Cell LymphomaYi-Qi Li, Chun-Ling Luo, Jia-Xin Jiang, et al.
Leukemia|December 20, 2024
Genetic susceptibility of diffuse large B-cell lymphoma: a meta genome-wide association study in Asian populationQian Cui, Wen Tan, Bao Song, et al.
Cancer Discovery|June 19, 2012
Janus kinase 3-activating mutations identified in natural killer/T-cell lymphomaGhee Chong Koo, Soo Yong Tan, Tiffany Tang, et al.
Blood Cancer Journal|November 14, 2018
Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK/T cell lymphomaJason Yongsheng Chan, Alvin Yu Jin Ng, Chee Leong Cheng, et al.
Cancers|January 22, 2021
T-Cell Lymphoma Clonality by Copy Number Variation Analysis of T-Cell Receptor GenesMing Liang Oon, Jing Quan Lim, Bernett Lee, et al.
Blood|September 29, 2019
Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistryCatalina Amador, Timothy C Greiner, Tayla B Heavican, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2024
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP TrialVincent Camus, Catherine Thieblemont, Philippe Gaulard, et al.
The Lancet. Oncology|February 14, 2016
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysisSeok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard, et al.
Pageof 19